Serial #79226295
LIVE

Serial Number

79226295

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 14, 2017

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79226295 Trademark

Serial Number: 79226295 • Registration: 5527128

Serial #79226295 is a trademark filed by NOVARTIS AG on November 14, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 14, 2017

Registration Date

July 31, 2018

Published for Opposition

May 15, 2018

Cancellation Date

February 14, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
May 7, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 15, 2026 INTS
INVALIDATION PROCESSED
Apr 15, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 14, 2025 INTR
CANCELLED SECTION 71
Feb 14, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 31, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 8, 2018 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Nov 16, 2018 FICS
FINAL DISPOSITION PROCESSED
Nov 16, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 31, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 31, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 15, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 15, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 25, 2018 NONP
ASSIGNED TO LIE
Apr 12, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2018 CNSA
REFUSAL PROCESSED BY IB
Mar 30, 2018 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 16, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 16, 2018 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 12, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 12, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 6, 2018 RFCR
NON-FINAL ACTION WRITTEN
Mar 5, 2018 CNRT
ASSIGNED TO EXAMINER
Feb 26, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 16, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 9, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 8, 2018 REPR